ONC201 kills breast cancer cells in vitro by targeting mitochondria
暂无分享,去创建一个
K. Nagashima | W. Reinhold | Y. Pommier | M. Hafner | W. Linehan | J. Shetty | V. Rajapakse | Bao Tran | C. Stuelten | S. Lipkowitz | R. Weigert | Xiantao Wang | Natalie Porat-Shliom | Maggie Cam | L. Gattinoni | Y. Ji | D. Crooks | V. Koparde | M. Lang | Samuel F. Gilbert | Y. Greer | D. Voeller | P. Jailwala | F. Soheilian | Celia Islam | Ashley Ubaldini | V. Kopardé | Samuel F Gilbert | Yun Ji | Natalie Porat‐Shliom | Parthav Jailwala | W. M. Linehan | Jyoti Shetty | Vishal N. Koparde | Samuel F. Gilbert | William Reinhold
[1] Jaak Vilo,et al. ClustVis: a web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap , 2015, Nucleic Acids Res..
[2] R. Paules,et al. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. , 2003, Molecular cell.
[3] J. Nunnari,et al. Mitochondrial form and function , 2014, Nature.
[4] A. Garnier,et al. Transcriptional control of mitochondrial biogenesis: the central role of PGC-1alpha. , 2008, Cardiovascular research.
[5] R. Scarpulla,et al. PGC-1-Related Coactivator, a Novel, Serum-Inducible Coactivator of Nuclear Respiratory Factor 1-Dependent Transcription in Mammalian Cells , 2001, Molecular and Cellular Biology.
[6] Mark J. Smyth,et al. The TRAIL apoptotic pathway in cancer onset, progression and therapy , 2008, Nature Reviews Cancer.
[7] J. Locasale,et al. The Warburg Effect: How Does it Benefit Cancer Cells? , 2016, Trends in biochemical sciences.
[8] S. Joshi,et al. ATP synthase complex from bovine heart mitochondria: the oligomycin sensitivity conferring protein is essential for dicyclohexyl carbodiimide-sensitive ATPase. , 1991, Biochimica et biophysica acta.
[9] W. Reinhold,et al. Using CellMiner 1.6 for Systems Pharmacology and Genomic Analysis of the NCI-60 , 2015, Clinical Cancer Research.
[10] R. McPherson,et al. Galactose Enhances Oxidative Metabolism and Reveals Mitochondrial Dysfunction in Human Primary Muscle Cells , 2011, PloS one.
[11] J. Auwerx,et al. The mitochondrial unfolded protein response, a conserved stress response pathway with implications in health and disease , 2014, Journal of Experimental Biology.
[12] John Calvin Reed,et al. Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities , 2008, Nature Reviews Drug Discovery.
[13] R. Candau,et al. The role of AMP-activated protein kinase in the coordination of skeletal muscle turnover and energy homeostasis. , 2012, American journal of physiology. Cell physiology.
[14] Dongchon Kang,et al. Frequent truncating mutation of TFAM induces mitochondrial DNA depletion and apoptotic resistance in microsatellite-unstable colorectal cancer. , 2011, Cancer research.
[15] E. Messaris,et al. Dual Inactivation of Akt and ERK by TIC10 Signals Foxo3a Nuclear Translocation, TRAIL Gene Induction, and Potent Antitumor Effects , 2013, Science Translational Medicine.
[16] H. Jacobs,et al. Alterations to the expression level of mitochondrial transcription factor A, TFAM, modify the mode of mitochondrial DNA replication in cultured human cells , 2006, Nucleic acids research.
[17] W. El-Deiry,et al. ONC201 kills solid tumor cells by triggering an integrated stress response dependent on ATF4 activation by specific eIF2α kinases , 2016, Science Signaling.
[18] G. Barsh,et al. Mitochondrial transcription factor A is necessary for mtDNA maintance and embryogenesis in mice , 1998, Nature Genetics.
[19] R. DiPaola,et al. First-in-Human Clinical Trial of Oral ONC201 in Patients with Refractory Solid Tumors , 2017, Clinical Cancer Research.
[20] John Calvin Reed,et al. Endoplasmic reticulum stress: cell life and death decisions. , 2005, The Journal of clinical investigation.
[21] R. Gilkerson,et al. The mitochondrial nucleoid: integrating mitochondrial DNA into cellular homeostasis. , 2013, Cold Spring Harbor perspectives in biology.
[22] P. Fortina,et al. The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma , 2009, Cell cycle.
[23] W. Linehan,et al. UOK 262 cell line, fumarate hydratase deficient (FH-/FH-) hereditary leiomyomatosis renal cell carcinoma: in vitro and in vivo model of an aberrant energy metabolic pathway in human cancer. , 2010, Cancer genetics and cytogenetics.
[24] G. Attardi,et al. The mtDNA‐encoded ND6 subunit of mitochondrial NADH dehydrogenase is essential for the assembly of the membrane arm and the respiratory function of the enzyme , 1998, The EMBO journal.
[25] Mila Ljujic,et al. The integrated stress response , 2016, EMBO reports.
[26] R. Scarpulla,et al. PGC-1-Related Coactivator: Immediate Early Expression and Characterization of a CREB/NRF-1 Binding Domain Associated with Cytochrome c Promoter Occupancy and Respiratory Growth , 2006, Molecular and Cellular Biology.
[27] D. Wallace,et al. Nonviability of cells with oxidative defects in galactose medium: a screening test for affected patient fibroblasts. , 1992, Biochemical medicine and metabolic biology.
[28] F. Urano,et al. Compartment-specific perturbation of protein handling activates genes encoding mitochondrial chaperones , 2004, Journal of Cell Science.
[29] P. Dennis,et al. Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2. , 2001, Cancer research.
[30] W. El-Deiry,et al. ONC201 Demonstrates Antitumor Effects in Both Triple-Negative and Non–Triple-Negative Breast Cancers through TRAIL-Dependent and TRAIL-Independent Mechanisms , 2017, Molecular Cancer Therapeutics.
[31] P. Dimroth,et al. Essentials for ATP synthesis by F1F0 ATP synthases. , 2009, Annual review of biochemistry.
[32] D. Hardie,et al. AMPK: a nutrient and energy sensor that maintains energy homeostasis , 2012, Nature Reviews Molecular Cell Biology.
[33] M. B. Jensen,et al. Mitochondrial proteostasis in the control of aging and longevity. , 2014, Cell metabolism.
[34] Rodrigue Rossignol,et al. Energy Substrate Modulates Mitochondrial Structure and Oxidative Capacity in Cancer Cells , 2004, Cancer Research.
[35] P. Holland. Death receptor agonist therapies for cancer, which is the right TRAIL? , 2014, Cytokine & growth factor reviews.
[36] Thomas R. Gingeras,et al. STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..
[37] K. Inoki,et al. AMPK and mTOR in cellular energy homeostasis and drug targets. , 2012, Annual review of pharmacology and toxicology.
[38] Kjell Hultenby,et al. Mitochondrial transcription factor A regulates mtDNA copy number in mammals. , 2004, Human molecular genetics.
[39] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[40] P. Meltzer,et al. TRAIL induces apoptosis in triple-negative breast cancer cells with a mesenchymal phenotype , 2008, Breast Cancer Research and Treatment.
[41] Yvonne Will,et al. Circumventing the Crabtree effect: replacing media glucose with galactose increases susceptibility of HepG2 cells to mitochondrial toxicants. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[42] W. El-Deiry,et al. TRAIL receptor signaling and therapeutics , 2010, Expert opinion on therapeutic targets.
[43] T. Kuwana,et al. Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax/Bak-dependent mitochondrial outer membrane permeabilization. , 2008, Developmental cell.
[44] M. Owen,et al. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. , 2000, The Biochemical journal.
[45] M. Nau,et al. Chemotherapy augments TRAIL-induced apoptosis in breast cell lines. , 1999, Cancer research.
[46] S. Lipkowitz,et al. ONC201: Stressing tumors to death , 2016, Science Signaling.
[47] P. Wen,et al. A phase 2 study of the first imipridone ONC201, a selective DRD2 antagonist for oncology, administered every three weeks in recurrent glioblastoma , 2017, Oncotarget.
[48] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[49] Lawrence Buja,et al. Oncosis: an important non-apoptotic mode of cell death. , 2012, Experimental and molecular pathology.
[50] W. El-Deiry,et al. Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathway , 2015, Molecular Cancer.
[51] M. Palacín,et al. Mitochondrial fusion proteins: dual regulators of morphology and metabolism. , 2010, Seminars in cell & developmental biology.
[52] Kenneth M. Yamada,et al. Direct comparisons of the morphology, migration, cell adhesions, and actin cytoskeleton of fibroblasts in four different three-dimensional extracellular matrices. , 2011, Tissue engineering. Part A.
[53] A. Ashkenazi. Targeting the extrinsic apoptotic pathway in cancer: lessons learned and future directions. , 2015, The Journal of clinical investigation.
[54] J. Wagner,et al. Reverse Warburg effect in a patient with aggressive B-cell lymphoma: is lactic acidosis a paraneoplastic syndrome? , 2013, Seminars in oncology.
[55] R. Scarpulla. Transcriptional paradigms in mammalian mitochondrial biogenesis and function. , 2008, Physiological reviews.
[56] Gen Sheng Wu,et al. ONC201 activates ER stress to inhibit the growth of triple-negative breast cancer cells , 2017, Oncotarget.
[57] Andrea Glasauer,et al. Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis , 2014, eLife.
[58] Pablo E. Morales,et al. Mitochondrial metabolism and the control of vascular smooth muscle cell proliferation , 2014, Front. Cell Dev. Biol..
[59] E. D. de Vries,et al. Translating TRAIL-receptor targeting agents to the clinic. , 2013, Cancer letters.
[60] K. Hashiguchi,et al. Establishment of human cell lines lacking mitochondrial DNA. , 2009, Methods in molecular biology.
[61] Colin N. Dewey,et al. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome , 2011, BMC Bioinformatics.
[62] Cole M. Haynes,et al. Metabolism and the UPR(mt). , 2016, Molecular cell.
[63] G. Salvesen,et al. Regulated cell death: signaling and mechanisms. , 2014, Annual review of cell and developmental biology.
[64] F. Sotgia,et al. Using the “reverse Warburg effect” to identify high-risk breast cancer patients , 2012, Cell cycle.
[65] C. Koumenis,et al. Cell intrinsic and extrinsic activators of the unfolded protein response in cancer: Mechanisms and targets for therapy. , 2015, Seminars in cancer biology.
[66] J. Nunnari,et al. Mitochondria: In Sickness and in Health , 2012, Cell.
[67] Michael L. Wang,et al. ATF4 induction through an atypical integrated stress response to ONC201 triggers p53-independent apoptosis in hematological malignancies , 2016, Science Signaling.
[68] U. Matthey,et al. Crucial role of the membrane potential for ATP synthesis by F(1)F(o) ATP synthases. , 2000, The Journal of experimental biology.
[69] Chris Sander,et al. rcellminer: exploring molecular profiles and drug response of the NCI-60 cell lines in R , 2016, Bioinform..
[70] J. Herman,et al. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[71] W. El-Deiry,et al. ONC201 induces cell death in pediatric non-Hodgkin's lymphoma cells , 2015, Cell cycle.